Wells Fargo Maintains Overweight on Enovis, Lowers Price Target to $33
Benzinga Newsdesk 1 month ago
NewsPrice TargetAnalyst Ratings
Wells Fargo analyst Larry Biegelsen maintains Enovis (NYSE:ENOV) with a Overweight and lowers the price target from $39 to $33.
Wells Fargo analyst Larry Biegelsen maintains Enovis (NYSE:ENOV) with a Overweight and lowers the price target from $39 to $33.